A study to determine the effectiveness of wearable gait rehabilitation robot therapy in gait training for patients with pediatric neuromuscular disorders

Effects of Wearable Exo skeletal robot-assisted gait training on gait ability in pediatric patients with Neuromuscular Disorders

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0012370

Enrollment

Registered

2026-07-31

Start date

2025-01-15

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Inpatients: 30 minutes per session, 5 times a week, for a total of 10 sessions over 2 weeks. Outpatients: 30 minutes per session, once a week, for a total of 10 sessions over 10 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Males and females aged 2 to 18 years diagnosed with pediatric neuromuscular disorders 2) Individuals meeting the applicable height range (115–150 cm) and applicable maximum weight (50 kg or less) 3) Individuals with a Functional Ambulatory Category (FAC) score of 1–3 4) Individuals possessing the cognitive ability to understand and execute instructions 5) Individuals who fully understand the research objectives and procedures and wish to participate in the clinical study through voluntary consent

Exclusion criteria

Exclusion criteria: 1) Individuals with cognitive impairments unable to understand instructions 2) Individuals who have received Botox injections or orthopedic surgery within the past 3 months 3) Individuals with severe lower limb spasticity with an MAS score of 3 or higher 4) Individuals who do not meet age criteria 5) Individuals whose use is restricted due to skin abnormalities or joint contractures 6) Individuals suspected of having a neurological disorder during a physical examination 7) Individuals with underlying neurological disorders 8) Individuals weighing 80 kg or more 9) Individuals whose foot size does not fall within the 170–290 mm range 10) Individuals deemed unsuitable for participation in the clinical study by the researcher for other reasons

Design outcomes

Primary

Measure	Time frame
1-minute walking distance;10-meter walking speed	—

Secondary

Measure	Time frame
Gross Motor Function Measure;Berg Balance Scale, Functional Reach Test, Timed Up to Go test, Five Times Sit to Stand Test;Left/right hip and knee angles according to the gait cycle (kinematic graph);Walking speed, number of steps, step length (spatio-temporal index)	—

Countries

Korea, Republic of

Contacts

Public ContactYun-Ju Jo

Jeonbuk National University Hospital

yjjo@mdctc.or.kr+82-63-259-3477

Outcome results